Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities

Add a new RSS channel


Find news

Tag: positive

Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

2018-08-16 13:00:00| PR Newswire: Financial

TARRYTOWN, N.Y. and JERUSALEM, Aug. 16, 2018 /PRNewswire/ -- Data include final primary efficacy results and an interim safety analysis Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive topline results...

Tags the or results positive

Biohaven Reports Positive Results From Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety

2018-08-16 09:00:00| PR Newswire: Automotive Industry

NEW HAVEN, Conn., Aug. 16, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company"), a clinical-stage biopharmaceutical company developing novel treatments for neurological disorders, announced today positive results from a double-blind, ...

Tags results reports positive trial

Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1

2018-08-15 08:00:00| PR Newswire: Multicultural News

CORK, Ireland, Aug. 15, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today confirmed positive topline results from the global, Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS) study of the first investigational long-acting injectable...

Tags the of results long

Actinium to Provide Update on Pivotal Phase 3 SIERRA Trial Following Positive Data Monitoring Committee Meeting

2018-08-14 22:05:00| PR Newswire: Health / Biotech

NEW YORK, Aug. 14, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or "the Company"), today announced that it will conduct a conference call on Wednesday, August 15, 2018 at 9:00 AM ET to provide an update on the Pivotal Phase 3 SIERRA Trial (Study of ...

Tags data provide update positive

JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer

2018-08-10 03:24:00| PR Newswire: Automotive Industry

HSINCHU, Taiwan and WUHAN, China, Aug. 9, 2018 /PRNewswire/ -- JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for its proposed...

Tags iii global positive advice


Sites : [1] [2] next »

Privacy policy . Copyright . Contact form .